Q32 Bio (QTTB) Current Leases (2020 - 2023)
Q32 Bio's (QTTB) quarterly Current Leases came in at $1.3 million in Q4 2023, down 15.57% year-on-year from $1.6 million in Q4 2022, and down 25.87% quarter-over-quarter from $1.8 million in Q3 2023.
Q32 Bio (QTTB) Current Leases (2020 - 2023) Analysis & Trends
Q32 Bio's Current Leases history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2023.
- On a quarterly basis, Current Leases fell 15.57% year-over-year to $1.3 million in Q4 2023; TTM through Dec 2023 was $1.3 million, a 15.57% decrease from a year earlier, with the FY2023 full-year figure at $1.3 million, down 15.57% from the prior year.
- Current Leases eased to $1.3 million in Q4 2023 per QTTB's latest filing, from $1.8 million in the prior quarter.
- Across five years, Current Leases topped out at $2.5 million in Q4 2020 and bottomed at $246000.0 in Q4 2021.
- The 4-year median for Current Leases is $1.7 million (2023), against an average of $1.7 million.
- Across the five-year window, Current Leases tumbled 90.16% in 2021 and surged 534.55% in 2022, its largest moves.
- Year by year, Current Leases stood at $2.5 million in 2020, then tumbled by 90.16% to $246000.0 in 2021, then jumped by 534.55% to $1.6 million in 2022, then fell by 15.57% to $1.3 million in 2023.
- Per Business Quant, the three latest QTTB Current Leases figures stand at $1.3 million (Q4 2023), $1.8 million (Q3 2023), and $1.7 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 410,000.00 |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 2.14 Mn |
| Mar 31, 2021 | 2.32 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 2.50 Mn |
| Jun 30, 2020 | 2.41 Mn |
| Mar 31, 2020 | 2.33 Mn |